Biogen, Inc. (BIIB)
218.11
+1.33
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
0.00 (0.00%)
After-Hours: 20:00
Biogen Total Return Level : 216.78 for Aug. 21, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 21, 2026 | 216.78 |
| August 20, 2026 | 214.35 |
| August 19, 2026 | 221.56 |
| August 18, 2026 | 212.55 |
| August 17, 2026 | 209.15 |
| August 14, 2026 | 209.83 |
| August 13, 2026 | 210.65 |
| August 12, 2026 | 208.87 |
| August 11, 2026 | 203.89 |
| August 10, 2026 | 207.13 |
| August 07, 2026 | 207.94 |
| August 06, 2026 | 206.28 |
| August 05, 2026 | 206.63 |
| August 04, 2026 | 208.45 |
| August 03, 2026 | 201.82 |
| July 31, 2026 | 202.95 |
| July 30, 2026 | 207.93 |
| July 29, 2026 | 209.23 |
| July 28, 2026 | 205.61 |
| July 27, 2026 | 200.14 |
| July 24, 2026 | 202.19 |
| July 23, 2026 | 200.62 |
| July 22, 2026 | 197.74 |
| July 21, 2026 | 203.16 |
| July 20, 2026 | 199.95 |
| Date | Value |
|---|---|
| July 17, 2026 | 205.99 |
| July 16, 2026 | 208.92 |
| July 15, 2026 | 197.24 |
| July 14, 2026 | 191.95 |
| July 13, 2026 | 209.03 |
| July 10, 2026 | 199.15 |
| July 09, 2026 | 198.91 |
| July 08, 2026 | 200.36 |
| July 07, 2026 | 205.70 |
| July 06, 2026 | 208.46 |
| July 02, 2026 | 216.12 |
| July 01, 2026 | 209.74 |
| June 30, 2026 | 216.06 |
| June 29, 2026 | 216.63 |
| June 26, 2026 | 216.03 |
| June 25, 2026 | 201.96 |
| June 24, 2026 | 199.59 |
| June 23, 2026 | 197.19 |
| June 22, 2026 | 199.71 |
| June 18, 2026 | 196.58 |
| June 17, 2026 | 198.67 |
| June 16, 2026 | 195.61 |
| June 15, 2026 | 198.64 |
| June 12, 2026 | 200.05 |
| June 11, 2026 | 199.96 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Ionis Pharmaceuticals, Inc. | 59.74 |
| AbbVie, Inc. | 456.39 |
| Gilead Sciences, Inc. | 212.96 |
| Vertex Pharmaceuticals, Inc. | 548.05 |
| Amgen, Inc. | 657.87 |